Brief: Genevant Sciences And Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna
03/03/2025 14:48
March 3 (Reuters) - Arbutus Biopharma Corp ABUS.O: GENEVANT SCIENCES AND ARBUTUS BIOPHARMA INITIATE INTERNATIONAL PATENT INFRINGEMENT ENFORCEMENT ACTIONS AGAINST MODERNA GENEVANT: SEEKING MONETARY RELIEF, INJUNCTIONS AGAINST SPIKEVAX &, WHERE APPLICABLE, ADDITIONAL PRODUCTS THAT MODERNA REPRESENTED USE SAME LNP TECH Source text: ID:nGNXc8Pw7W Further company coverage: ABUS.O (Reuters.Briefs@thomsonreuters.com)
Recent news on Roivant Sciences
See all newsU.S. STOCKS ON THE MOVE-Thermo Fisher, CME, Capital One, Northern Trust
Roivant rises as drug succeeds in two late-stage trials for eye disease
Immunovant falls after lupus drug setback
Brief: Roivant Announces Topline Results From Proof-Of-Concept Study Of Imvt-1402 In Cutaneous Lupus Erythematosus
U.S. STOCKS ON THE MOVE-Best Buy, Peloton, Apple